1. The role of β-catenin and paired-like homeobox 2B (PHOX2B) expression in neuroblastoma patients; predictive and prognostic value
   Samar S. El-Shazly et al, 2019, Experimental and Molecular Pathology CrossRef
2. Plasma cell‐free DNA quantification is highly correlated to tumor burden in children with neuroblastoma
   Xisi Wang et al, 2018, Cancer Medicine CrossRef
3. Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastoma
   Yan Su et al, 2019, Cancer Medicine CrossRef
4. Minimal residual disease in high-risk neuroblastoma shows a dynamic and disease burden-dependent correlation between bone marrow and peripheral blood
   Kyaw San Lin et al, 2021, Translational Oncology CrossRef
5. Increased plasma concentration of cell-free DNA precedes disease recurrence in children with high-risk neuroblastoma
   Yan Su et al, 2020, BMC Cancer CrossRef
6. Cytokine‑induced killer cells/natural killer cells combined with anti‑GD2 monoclonal antibody increase cell death rate in neuroblastoma SK‑N‑SH cells
   Chi Zhang et al, 2019, Oncology Letters CrossRef
7. Discovery of Spatial Peptide Signatures for Neuroblastoma Risk Assessment by MALDI Mass Spectrometry Imaging
   Zhiyang Wu et al, 2021, Cancers CrossRef